Eikon Therapeutics
Andrew Theodorides began working as a Software Engineer at Eikon Therapeutics in May 2021. Prior to this, they worked as a Web Developer at The Genome Center from November 2018 to May 2020.
Andrew Theodorides completed their high school education at Lowell High School from 2012 to 2016. Andrew then attended City College of San Francisco from 2016 to 2018. Following that, they pursued a degree in Computer Science at the University of California, Davis from 2018 to 2020.
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.